Scientists Differentiate Healthy and Cancerous Cells by Their Movement Patterns

In a groundbreaking development from Tokyo Metropolitan University, researchers have unveiled a novel approach for distinguishing cancerous cells from healthy ones by meticulously tracking their natural movements without the need for any fluorescent labeling. Utilizing phase-contrast microscopy, a label-free imaging technique, the team observed the distinct migratory behaviors of malignant fibrosarcoma cells and healthy fibroblasts cultured on a dish. Their meticulous analysis revealed that subtle differences in the shape and curvature of cellular trajectories serve as reliable indicators to differentiate between these two cell types with an impressive accuracy of up to 94 percent.

For centuries, cell analysis under the microscope has predominantly focused on static characteristics such as morphological features, internal composition, or the identification of specific molecular markers through various staining techniques. However, these methods overlook the dynamic nature of living cells, which continuously move and reshape themselves in response to both intrinsic programs and external cues. The researchers’ innovative shift towards investigating cell motility recognizes that cell migration patterns — particularly those associated with cancer metastasis — carry profound biological significance that can be harnessed for diagnostic purposes.

Tracking cell movement with precision over time has historically presented formidable challenges. Manual observation of limited cell populations risks bias, while many automated tracking systems rely heavily on fluorescent labels to enhance visibility. Despite their utility, fluorescent dyes can inadvertently alter cellular properties, potentially confounding results and limiting clinical translatability. The aspiration, therefore, has been to establish a fully automated, high-throughput method for monitoring cell migration in a label-free manner, preserving cells in conditions closer to their physiological states.

The Tokyo Metropolitan University team, led by Professor Hiromi Miyoshi, achieved this ambition by leveraging phase-contrast microscopy, an optical imaging technique prized for its ability to visualize transparent specimens without exogenous markers. Phase-contrast microscopy exploits differences in refractive indices within cells and their surrounding medium to generate contrast, allowing detailed visualization of living cells on plastic petri dishes without disturbing their motility or viability. This technique bypasses the optical distortions or interferences often encountered when imaging through standard culture dishes, ensuring authentic recording of cellular movements.

To decode the complex migratory behaviors of individual cells, the researchers applied sophisticated image analysis algorithms to extract and reconstruct the trajectories of numerous single cells from time-lapse phase-contrast videos. They quantitatively characterized the paths using metrics such as migration speed and the “sum of turn angles,” which measures how frequently and sharply cells change their direction. Notably, the frequency of shallow turns and the overall curvature of the trajectories emerged as pivotal parameters encoding subtle mechanical and morphological disparities between cancerous and non-cancerous cells.

A direct comparison between healthy fibroblast cells — essential structural cells that form connective tissue and support wound healing — and malignant fibrosarcoma cells — aggressive cancer cells originating from fibrous connective tissues — underscored the diagnostic potential of this method. Despite their similar appearances, the migratory trajectories of these cells revealed distinct fingerprints. While normal fibroblasts tended to follow straighter, slower paths characterized by fewer shallow turns, the cancer cells exhibited more erratic and curvilinear movements. Capturing these nuanced differences enabled the research team to classify cell types with remarkable precision.

The implications of this research extend far beyond simple cancer cell discrimination. Since cellular motility underlies numerous physiological and pathological processes, including embryogenesis, immune responses, tissue regeneration, and metastatic progression, the presented label-free, quantitative tracking approach opens new avenues for exploring myriad biological functions. By reframing how we analyze cells—from static snapshots to dynamic trajectories—this technology could transform not only diagnostics but also our understanding of cellular biomechanics and behavior in health and disease.

Moreover, the automated, label-free aspect of this technique is particularly advantageous for clinical translation. Eliminating the need for fluorescent or chemical markers reduces costs, processing times, and risks of cell perturbation, thereby making real-time monitoring of patient-derived cells more feasible. Such an approach is invaluable for personalized medicine, where rapid identification of malignant cells in biopsy samples could enhance diagnostic accuracy and guide therapeutic decisions without extensive sample manipulation.

The researchers’ findings also hold promise for improving cancer prognosis. Since metastasis remains the deadliest attribute of many cancers, being able to detect subtle differences in migratory patterns could help predict the aggressiveness of tumors and their likelihood to spread. This insight might facilitate early intervention, improving patient outcomes through timely and targeted treatments. Tracking cell motility dynamics quantitatively might also serve as a platform for screening anti-metastatic drugs by revealing how candidate compounds modulate cancer cell movement in real time.

From a technical standpoint, the success of this study hinged on integrating advanced microscopy with computational image analysis. Automated extraction of trajectories from phase-contrast images demanded algorithms capable of noise reduction, precise cell segmentation, and accurate tracking over extended periods despite challenges like cell crowding, overlapping, and morphological changes. The researchers’ ability to reliably process large datasets without human intervention underscores the maturity of current bioimage informatics tools and their pivotal role in advancing biomedical research.

Crucially, this approach adheres closely to the native behavior of cells, avoiding artifacts introduced by labeling that might influence motility. Traditional fluorescent techniques often require genetic or chemical modification, which can alter cell metabolism, cytoskeletal dynamics, and signaling pathways, ultimately biasing observed behaviors. Observing cells in their near-physiological states enhances the biological relevance and translatability of findings, an essential consideration for clinical applications.

Furthermore, the study emphasizes that evaluating cell motility in bulk populations offers greater diagnostic robustness than analyzing isolated cells. The automated capacity to simultaneously monitor hundreds or thousands of cells minimizes sampling bias and enhances statistical confidence in differentiating healthy versus cancerous cells. This high-throughput paradigm also accelerates data acquisition, enabling timely analysis that could be critical in clinical contexts.

As the global scientific community continues to unravel the complexities of cancer biology, tools that exploit physical and dynamic cell characteristics complement traditional molecular and genetic analyses. The novel methodology presented by the Tokyo Metropolitan University research group exemplifies such integrative innovation, marrying classical microscopy with modern computational analysis to yield actionable biomedical insights.

In conclusion, this pioneering research marks a substantial leap toward label-free, non-invasive cancer cell identification based on motility profiles extracted through phase-contrast microscopy. The ability to discriminate malignant fibrosarcoma cells from healthy fibroblasts with 94% accuracy solely by analyzing their migratory paths opens exciting possibilities for diagnostics, drug development, and fundamental cell biology. As further refinements and validations ensue, this technology promises to become an invaluable asset in both research laboratories and clinical settings, enhancing our capacity to combat cancer and understand cell behavior in unprecedented detail.

—

Subject of Research: Cell motility-based discrimination between cancerous and healthy cells using label-free phase-contrast microscopy.

Article Title: Development of label-free cell tracking for discrimination of the heterogeneous mesenchymal migration

News Publication Date: 31-Mar-2025

Web References:
http://dx.doi.org/10.1371/journal.pone.0320287

Image Credits: Tokyo Metropolitan University

Keywords: Cancer research, Cell migration, Cancer cells, Image analysis, Fibroblasts, Metastasis, Speed, Cell polarity

Tags: accuracy in cell differentiationadvancements in microscopy for cell studycancer cell movement patternscell motility and cancer metastasiscellular trajectory analysis for diagnosticsdistinguishing healthy and cancerous cellsdynamic nature of living cellsfibrosarcoma cell migration behaviorsinnovative cancer diagnosis methodslabel-free imaging in cell analysisphase-contrast microscopy techniquesTokyo Metropolitan University research